Deutsche's big gamble

Article Abstract:

Deutsche Bank is to merge with Dresdner Bank and the new bank aims to succeed in investment banking. The new bank will move away from retail banking despite uncertainties relating to the wholesale strategy of Deutsche Bank. Dresdner and Deutsche combined account for 12% of German retail banking and face pressure from savings and mutual banks that do not have to achieve market rates of return. Bank 24 will become an independent company, and Allianz will exchange stakes in Dresdner and Deutche Bank for a stake of 49% in Bank 24.

---

Death of a deal

Article Abstract:

A planned merger between Dresdner Bank and Deutsche Bank has collapsed after it was called off by Dresdner Bank, and this is linked to problems in merging the two banks' investment bank operations. There had been a plan to merge the investment bank of Deutsche bank with Dresdner Kleinwort Benson (DKB), and Dresdner would have suffered a revolt if the breaking up of DKB had been agreed. Some key Deutsche Bank staff were also opposed to the planned merger.

---

Dresdner approval is expected in sale of unit's divisions

Article Abstract:

Dresdner Kleinwort Benson's equities and fixed-income divisions were announced as available for sale by Dresdner Bank AG and Deutsche Bank AG. Several financial institutions have already expressed interest to acquire the investment bank's assets.

Asset sales & divestitures, Acquisitions & mergers, Germany, Croatia, Statistical Data Included, Brief Article, Dresdner Kleinwort Benson, DTBKY

Similar abstracts:

• Abstracts: Dresdner Bank continues to look into acquisitions. NatWest considers restructuring plan. Bank of Scotland adds cash to bid
• Abstracts: Despite earnings slip, Intel expects a good 2nd half. Intel's earnings miss forecasts; IBM does better. Intel Corp. earnings beat expectations
• Abstracts: Valeo's net income is widely expected to fall nearly 50%. Strong sales lift Valeo's results. Valeo posts strong results; chairman to step down
• Abstracts: P&G's net profit rises 6%, bolstered by sale of Clearasil. Procter & Gamble disappoints with 4th-quarter outlook
• Abstracts: All sorts of conditions of men. Courting controversy. Casting a light

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.